SafeGuard:
Redefining
Surgery

LeakGuard™: the only FDA breakthrough product of its kind.

SafeGuard Surgical is redefining post-operative care with groundbreaking innovation. Our scalable surgical platform is built to eliminate complications, reduce costs, and improve patient outcomes.

At the core of this revolution is LeakGuard™, the only FDA breakthrough stent of its kind, designed to prevent surgical leaks without the need for removal.

Surgical complications drive up costs and prolong recovery, creating unnecessary risks for patients and burdens on healthcare systems. SafeGuard Surgical delivers a smarter, more efficient solution—one that enhances healing, cuts expenses, and eliminates waste. With a patented, U.S.-manufactured technology, we’re not just improving surgery—we’re setting a new industry standard.

Our founder

DR. SCOTT KELLEY

Dr. Kelley serves as CEO of SafeGuard Surgical. As an innovator and an accomplished Ivy League cancer surgeon, he has held leadership roles at some of the largest healthcare institutions.

As an accomplished inventor and innovator, he serves as a global healthcare advisor to countries and multinational companies on emerging technology.

Evolution of Leakguard

2018
2018

SafeGuard is Trademarked and Incorporated

2022
2022

Dr. Kelley sells his medical practice to launch SafeGuard Surgical

2022
2022

Prototype developed and successfully tested

2023
2023

Family/friends investment round led by NFL QB Jameis Winston

Z

FDA Breakthrough Designation

2024
2024

Fund led by philanthropist Tom Pepin

Our Advisors

Eamonn Hobbs

justin Chickles

Deb Ramsdel

Dean Hu

Vishal Verma

Jill Kelley

Richard Toren

Safer surgeries, healthier humans.